Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

Abstract Background Nonsteroidal anti‐inflammatory drugs (NSAIDs) are frequently avoided in mastocytosis, because of a potential increased risk for drug hypersensitivity reactions (DHRs) due to inhibition of cyclo‐oxygenase (COX), subsequent depletion of prostaglandin E2 and release of leukotrienes....

Descripció completa

Dades bibliogràfiques

Autors principals:	Tiago Azenha Rama, José Mário Morgado, Ana Henriques, Luis Escribano, Iván Alvarez‐Twose, Laura Sanchez‐Muñoz, André Moreira, José Romão, Alberto Órfão, Almudena Matito
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2022-03-01
Col·lecció:	Clinical and Translational Allergy
Matèries:	anaphylaxis mast cell‐mediator release‐associated symptoms mast cells mastocytosis non‐steroidal anti‐inflammatory drug hypersensitivity
Accés en línia:	https://doi.org/10.1002/clt2.12132
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!